Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
ClinicalTrials.gov study NCT06281964. IPD Sharing: NO. Countries: 1. Publications: 0.
TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
ClinicalTrials.gov study NCT06818058. IPD Sharing: NO. Countries: 1. Publications: 0.
Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI
ClinicalTrials.gov study NCT04510415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
ClinicalTrials.gov study NCT03051880. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
ClinicalTrials.gov study NCT05007938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment
ClinicalTrials.gov study NCT01380262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients
ClinicalTrials.gov study NCT03171636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EGFR-targeted Therapy for Gastric Cancer
ClinicalTrials.gov study NCT04077255. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR
ClinicalTrials.gov study NCT00198159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
ClinicalTrials.gov study NCT04335292. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib for NSCLC With Uncommon EGFR Mutations
ClinicalTrials.gov study NCT05421936. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance
ClinicalTrials.gov study NCT04785729. IPD Sharing: NO. Countries: 1. Publications: 0.
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
ClinicalTrials.gov study NCT04324164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
ClinicalTrials.gov study NCT01790217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer
ClinicalTrials.gov study NCT03986541. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05401110. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04063462. IPD Sharing: YES. Countries: 1. Publications: 0.
Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)
ClinicalTrials.gov study NCT02043002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocar
ClinicalTrials.gov study NCT01443065. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30
ClinicalTrials.gov study NCT04592406. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.